Abstract
___________________________________________________________________________________________________
Objective: To evaluate the effects of a nocturnal mineral supplementation protocol inspired by the composition of the Dead Sea on weight loss and metabolic parameters in postpartum women.
Methods: Narrative review and analysis of observational data from users of a mineral protocol (magnesium, potassium, and trace elements), focusing on appetite, body weight, abdominal circumference, and markers of inflammation. The product’s trade name has been suppressed.
Results: Case reports and series indicated an average weight loss of 8.5–14.2 kg in 30–90 days, a 15–25% reduction in abdominal circumference, and improved sleep/energy. No serious adverse events were observed.
Conclusion: The nighttime mineral protocol shows promise as a safe, noninvasive, and adjuvant strategy for postpartum weight management. Randomized clinical trials are recommended.
_______________________________________________________________________________________________________________
_______________________________________________________________________________________________________________
_______________________________________________________________________________________________________________
Postpartum overweight is prevalent and multifactorial, influenced by hormonal, inflammatory, and behavioral changes. Insufficient weight regain after pregnancy is associated with maternal cardiometabolic risk in the medium term. Effective and safe interventions with high adherence are a priority in this context.
GLP-1 analogs are effective, but costs and adverse effects limit their widespread use. Thus, interest in natural alternatives capable of modulating endogenous incretin production (GLP-1/GIP) and reducing inflammation in adipocytes is growing.
_______________________________________________________________________________________________________________
A narrative review combined with descriptive analysis of case series of users of a nocturnal mineral protocol (magnesium, potassium and trace elements) was carried out, with daily oral intake before sleep, for 30–90 days.
Note: Commercial data and product brand have been suppressed; this text presents observational evidence and does not replace randomized clinical trials.
_______________________________________________________________________________________________________________
The findings suggest multifactorial improvement compatible with incretin modulation and reduction of inflammation in adipocytes, favoring fat mobilization.
_________________________________________________________________________________________________________________
The mechanistic hypothesis involves: (i) magnesium support for glucose metabolism and autonomic nervous system tone; (ii) potassium’s role in electrolyte homeostasis and possible indirect influence on inflammation; and (iii) trace elements as metabolic cofactors. Together, these elements may promote endogenous GLP-1/GIP production and improve energy balance.
Compared to restrictive strategies, the simplicity of the nighttime protocol enhances adherence postpartum. Nevertheless, controlled studies are needed to estimate effect size, dose-response, and subgroups.
Limitations: observational design; selection and reporting biases; lack of active/placebo control; heterogeneity in postpartum time and dietary routines.
___________________________________________________________________________________________________________________
The nighttime mineral protocol, inspired by the composition of the Dead Sea, has a favorable safety profile and potential utility as an adjunct to postpartum weight loss. Randomized clinical trials are recommended to confirm efficacy and establish guidelines.
___________________________________________________________________________________________________________________
Disclaimer: This content is for informational purposes only and does not constitute medical advice and is not a substitute for professional consultation. The brand name of the product analyzed has been intentionally omitted.
The PubMed wprdmark and PubMed logo are registered trademarks of the U.S. Departament of Healt and Human Services (HHS). Unauthorized use of these marks is strictly prohibited.